Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +17.01%
#3 Orochi Network Orochi Network +10.19%
#4 Pump.fun Pump.fun +9.55%
#5 Unit Pump Unit Pump +9.55%
#6 eCash eCash +9.31%
#7 Fake World Assets Fake World Assets +8.82%
#8 OPENLOOT OPENLOOT +8.48%
#9 Meteora Meteora +8.22%
#10 Glidr Glidr +8.12%
Coin of the day
PulseChain PulseChain
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Rang in Aktien #28164
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Aktienkurs
$0.5495
Zuletzt synchronisiert: 2025-05-15
Marktkapitalisierung
$28.14M
Veränderung (1 Tag)
4.70%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Enzo Biochem, Inc. (ENZ)

Kategorie

Healthcare
Umsatz von Enzo Biochem, Inc. (ENZ)
Umsatz im Apr 2025 TTM: $27.48M
Laut den aktuellen Finanzberichten von Enzo Biochem, Inc. beträgt der derzeitige Umsatz des Unternehmens (TTM) $27.48M. Im Jahr 2023 erzielte das Unternehmen einen Umsatz von $31.06M ein Rückgang im Vergleich zu dem Umsatz im Jahr 2022, der $107.07M betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Enzo Biochem, Inc. von 2000 bis 2026
Umsatz am Ende jedes Jahres
Jahr Umsatz ändert
2026 (TTM) $27.48M -13.89%
2024 $31.91M 2.72%
2023 $31.06M -70.99%
2022 $107.07M -9.05%
2021 $117.73M 54.87%
2020 $76.02M -6.34%
2019 $81.17M -22.48%
2018 $104.71M -2.87%
2017 $107.80M 4.90%
2016 $102.77M 5.30%
2015 $97.60M 1.72%
2014 $95.95M 2.39%
2013 $93.71M -9.10%
2012 $103.08M 1.03%
2011 $102.03M 5.10%
2010 $97.08M 8.38%
2009 $89.57M 15.14%
2008 $77.80M 47.04%
2007 $52.91M 32.85%
2006 $39.83M -8.24%
2005 $43.40M 4.22%
2004 $41.64M -21.08%
2003 $52.77M -2.31%
2002 $54.02M -7.52%
2001 $58.41M 16.75%
2000 $50.03M 0.00%
Umsatz vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Umsatz Umsatzunterschied Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B 168,547.86%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B 91,281.26%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B 9,752.87%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B 16,472.24%
US